RN7SKP256

Across TCGA pan-cancer cohorts, RN7SKP256 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RN7SKP256 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RN7SKP256 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SKP256 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

STAD, LUSC, and LUAD are the cancer types where RN7SKP256 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.438	0.676	<.001	117	view →
LUSC	OS	Tertile	II,III,IV	0.259	0.742	.021	36	view →
LUAD	OS	Tertile	All	0.264	0.686	.006	36	view →
LIHC	OS	Tertile	III,IV	0.118	0.615	.003	36	view →
BLCA	OS	Tertile	All	0.188	0.687	.020	18	view →
SKCM	DFS	Tertile	IV	0.016	0.541	.008	18	view →
PCPG	DFS	Tertile	All	0.086	0.846	.001	18	view →
LAML	DFS	Tertile	All	0.195	0.480	.011	18	view →
SARC	OS	Tertile	All	0.144	0.599	.001	18	view →
ESCA	OS	Tertile	III,IV	1.000	0.378	.026	15	view →
UVM	OS	Tertile	III,IV	0.220	0.872	.025	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RN7SKP256–STAD (DFS)

Open the STAD breakdown →